Litigation Details for Man-U Service Contract Trust Fund v. Teva Pharmaceuticals USA, Inc. (D. Conn. 2014)
✉ Email this page to a colleague
Man-U Service Contract Trust Fund v. Teva Pharmaceuticals USA, Inc. (D. Conn. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-09 |
| Court | District Court, D. Connecticut | Date Terminated | |
| Cause | MDL 2516 In Re: Aggrenox Antitrust Litigation | Assigned To | Stefan R. Underhill |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,015,577 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Man-U Service Contract Trust Fund v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Man-U Service Contract Trust Fund v. Teva Pharmaceuticals USA, Inc. (D. Conn. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2013-12-04 | 1 | Boehringer submitted Patent No. 6,015,577 (the “‘577 Patent”) to the FDA for listing in the… ‘577 Patent, asserting that its generic would not infringe the patents and/or that the patents were …name drug’s patents listed in the Orange Book, because either: a. no patents exist on the…; b. the patents have expired; c. the patents will expire by the time …manufacturer and the owner of the patent. If the brand manufacturer files a patent infringement lawsuit against | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
